Lec 1- introduction Flashcards
1
Q
Aim of clinical pharmaceutics lecture
A
- To demonstrate the importance of pharmaceutical knowledge in assessing information to ensure the safe and efficient use of medicines
- And the resolution of controversial issues
2
Q
Clinical pharmaceutics
A
3
Q
Who does/Knows what
A
- Pharmacology
- Diagnose: Doc/Nurse/Pharmacist
- Prescribe: Doc/Nurse/Pharmacist
- Pharmacy practice
- Dispensing: Pharm tec/Pharmacist/Nurse/Doc
- Pharmaceutics
- Drug delivery/formulation: Pharmacist
4
Q
Products for arthitis (Mercks manual 1899_
A
- Aconite
- As
- Colchicine
- Gold
- Li salts
- Hg salts
- KBr
- Saliformin- hexamine salicylate
5
Q
Monkshood (aconitine)
A
- Aconitine root- herbal remedy
- Aconitum napellus
- Not water soluble due to large ring structures = steric hinderence= water molecules can’t access H bond donor/acceptors
6
Q
Some uses of aconite (merck1899)
A
- Abcess
- Angina
- Arthitis
- Asthma
- Coughs
- Diptheria
- Enteritis
- Fever
7
Q
Strychnos Nux Vomica
A
- A source of strychnine used for exterminating moles
- In homeopathic world is used for:
- constipation
- flatulence
- indigestion
- stress
- Sore throat
8
Q
Atropa belladonna
A
- A source of atropine used to dilate the pupils
- In homoeopathic world
- Childbirth
- Croup
- Influenza
- Measles
- Mumps
- Pneumonia
9
Q
Things to demonstrate
A
- Is there valid clinical data to support these claims
- Are we recommending this instead of known effective clinical intervention
- What is best for the patient
10
Q
Examples: Excipients
A
- 1937- an elixir of sulphanilamide in the US
- Contained 10% diethylene glycol
- As a co-solvent to dissolve the sulphonamide
- Contained 10% diethylene glycol
- On sale for 2 months
- Killed at least 76 people
- Damage to liver and kidneys
- Killed at least 76 people
- In response- the FDA was established
- No thalidomide tragedy in the US
11
Q
Examples: Manufacturing Digoxin
A
- Digoxin- 1972
- Branded lanoxin
- Manufactured by Burroughs Wellcome (GSK)
- New process produced smaller particle size
- Increased bioavailability- 2-3 fold
- Therapeutic index (effective tolerated dose) ~2
- Toxicity to patients with fatalities
12
Q
A